(Durham, N.C. & Beijing, China) Further deepening its commitment to China, Quintiles today announced the launch of Kun Tuo, a local contract research organization (CRO) built to service the unique needs of the Chinese biopharmaceutical industry and multinational biopharma companies operating in China. Building on Quintiles’ unmatched success at the global level and experience in conducting clinical trials in China since 1997, Kun Tuo will focus on developing customized solutions to help local and global biopharma companies achieve successful registration of new medicines in China. (more…)

(Wilmington, N.C.) PPD, Inc. (Nasdaq: PPDI) announced it has been named to the 2011 InformationWeek 500, an annual list of the most innovative users of business technology in the United States. The award recognizes PPD’s leadership in technology investments, strategies and practices that contribute to effective drug discovery and development programs. PPD was recognized for PPD® PatientView, an innovative online portal linking clinical trial participants with biopharmaceutical companies, physicians and health care resources to enhance patient connectivity and improve patient retention in clinical trials. (more…)

(Research Triangle Park, N.C.) Novella Clinical, Inc., a full service contract research organization, today announced Michael (Mike) Boyd, Ph.D., has been named global head of clinical reporting where he has executive oversight for all Biostatistics and SAS programming activities within Novella Clinical. Leading Novella’s existing clinical reporting team, Dr. Boyd has responsibility for Novella’s four U.S. offices as well as operations in the United Kingdom and Russia. (more…)

(Durham, N.C.) Quintiles today reached a significant milestone in its prime site program with the official opening of a clinical research facility within Queen Mary, University of London. Queen Mary was Quintiles’ first prime site, with the collaboration dating back to 2007. Prime Sites are large clinical institutions that collaborate with Quintiles to drive productivity and excellence in clinical research. Quintiles provides dedicated resources to the clinical research facility to maximize patient recruitment and accelerate outcomes. (more…)

(Wilmington, N.C.) PPD, Inc. (Nasdaq: PPDI) announced it has appointed Edward Ian as vice president of clinical development for Asia Pacific. Mr. Ian will be based in Singapore and will provide strategic leadership and operational oversight for PPD’s Phase II-IV business in the region. (more…)

(Wilmington, N.C.) PPD, Inc. (Nasdaq: PPDI) announced it has appointed Edward Ian as vice president of clinical development for Asia Pacific. Mr. Ian will be based in Singapore and will provide strategic leadership and operational oversight for PPD’s Phase II-IV business in the region. (more…)

(Research Triangle Park, N.C.) Novella Clinical, Inc., a full service contract research organization, is proud to announce President & CEO Richard Staub is a 2011 Ernst & Young Entrepreneur of the Year Award Carolinas winner. The awards, which celebrate entrepreneurs who transform economies, drive innovation and change communities, were presented at a black-tie gala in Charlotte. Having joined Novella in 2004 as president and COO, Staub led the acquisition of three companies, raised head count to over 800 and bolstered revenue from $15.1 million in 2006 to over $100 million in 2010. (more…)

(Stevenage, England, and Research Triangle Park, N.C.) Novella Clinical, Inc., a full service contract research organization, today announced John Davidson has been named business development manager. In this new role, Davidson will be responsible for championing Novella’s clinical research and resourcing services with clients located in the United Kingdom and mainland Europe. Davidson has a long, successful track record of sales and account management within the biopharma and CRO industries having worked most recently as an account manager at Imperial Clinical Research Services, and previously as business development director at Paragon Biomedical. (more…)

(Wilmington, N.C.) PPD, Inc. (Nasdaq: PPDI) today announced it has been awarded the U.S. Army Medical Research Acquisition Activity: Regulatory Affairs & Compliance Support contract to provide global regulatory and biostatistical services for a range of clinical development programs funded by the U.S. Army. The award is a multi-year, indefinite delivery, indefinite quantity (IDIQ) contract with a ceiling value of $45.5 million over a five-year period beginning April 15, 2011. (more…)

(Research Triangle Park, N.C.) NCTechNews, North Carolina’s technology news source, will be blogging live from the BIO International Convention in Washington, D.C. June 27-30 to cover major trends affecting the life sciences community. The BIO International Convention is the largest global event of its kind, attracting the biggest names in biotech and featuring keynotes and sessions from key policymakers, scientists, CEOs, and celebrities, and the world’s largest biotechnology exhibition - the BIO Exhibition. (more…)

(Wilmington, N.C.) PPD, Inc. (Nasdaq: PPDI) today announced that N.C. Gov. Beverly Perdue has appointed Mike Wilkinson, Ph.D., executive vice president and chief information officer for PPD, to serve on the U.S.S. North Carolina Battleship Commission, where he will help oversee the administration and operation of the landmark state memorial and exhibit for World War II veterans. (more…)

(Research Triangle Park, N.C.) Novella Clinical, Inc., a full service contract research organization, today announced Richard (Rick) Farris has been named senior director for project management. Farris will be responsible for further enhancing Novella’s project management infrastructure, streamlining study management and oversight, and supplementing new business development within Novella’s biopharmaceutical division. (more…)